Bharat Biotech has sought India’s drug regulator DCGI’s approval to extend the shelf life of it’s Covid-19 vaccine Covaxin from six months to 24 months and has hence written a letter to the functionary body on Sunday, reports TOI.
Bharat Biotech seeks DCGI approval to extend the shelf life of Covaxin
previous post